BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28597291)

  • 21. Assessment of the role of nucleoside transporters, P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in the placental transport of entecavir using in vitro, ex vivo, and in situ methods.
    Cerveny L; Karbanova S; Karahoda R; Horackova H; Jiraskova L; Ali MNH; Staud F
    Toxicol Appl Pharmacol; 2023 Mar; 463():116427. PubMed ID: 36801311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta.
    Grube M; Reuther S; Meyer Zu Schwabedissen H; Köck K; Draber K; Ritter CA; Fusch C; Jedlitschky G; Kroemer HK
    Drug Metab Dispos; 2007 Jan; 35(1):30-5. PubMed ID: 17020956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs).
    Hofman J; Kučera R; Neumanova Z; Klimes J; Ceckova M; Staud F
    Xenobiotica; 2016; 46(5):416-23. PubMed ID: 26364927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on intestinal absorption of sulpiride (1): carrier-mediated uptake of sulpiride in the human intestinal cell line Caco-2.
    Watanabe K; Sawano T; Terada K; Endo T; Sakata M; Sato J
    Biol Pharm Bull; 2002 Jul; 25(7):885-90. PubMed ID: 12132663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple Drug Transporters Are Involved in Renal Secretion of Entecavir.
    Yang X; Ma Z; Zhou S; Weng Y; Lei H; Zeng S; Li L; Jiang H
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6260-70. PubMed ID: 27503646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure.
    Gedeon C; Behravan J; Koren G; Piquette-Miller M
    Placenta; 2006; 27(11-12):1096-102. PubMed ID: 16460798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oxygen on multidrug resistance in term human placenta.
    Javam M; Audette MC; Iqbal M; Bloise E; Gibb W; Matthews SG
    Placenta; 2014 May; 35(5):324-30. PubMed ID: 24685282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
    Bucher S; Le Vee M; Jouan E; Fardel O
    J Biochem Mol Toxicol; 2014 Mar; 28(3):119-28. PubMed ID: 24464585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mercury toxicokinetics of the healthy human term placenta involve amino acid transporters and ABC transporters.
    Straka E; Ellinger I; Balthasar C; Scheinast M; Schatz J; Szattler T; Bleichert S; Saleh L; Knöfler M; Zeisler H; Hengstschläger M; Rosner M; Salzer H; Gundacker C
    Toxicology; 2016 Jan; 340():34-42. PubMed ID: 26740192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
    Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta.
    Pollex E; Lubetsky A; Koren G
    Placenta; 2008 Aug; 29(8):743-7. PubMed ID: 18558430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors.
    Evseenko DA; Paxton JW; Keelan JA
    Drug Metab Dispos; 2007 Apr; 35(4):595-601. PubMed ID: 17237156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal Drug Transporters and Drug Interactions.
    Ivanyuk A; Livio F; Biollaz J; Buclin T
    Clin Pharmacokinet; 2017 Aug; 56(8):825-892. PubMed ID: 28210973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
    Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
    Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of the placental BCRP/ABCG2 transporter to lipid rafts: Role for cholesterol in mediating efflux activity.
    Szilagyi JT; Vetrano AM; Laskin JD; Aleksunes LM
    Placenta; 2017 Jul; 55():29-36. PubMed ID: 28623970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta.
    Gedeon C; Anger G; Piquette-Miller M; Koren G
    Placenta; 2008 Jan; 29(1):39-43. PubMed ID: 17923155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.
    Vaidya SS; Walsh SW; Gerk PM
    Mol Pharm; 2009; 6(6):1689-702. PubMed ID: 19397308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributions of Drug Transporters to Blood-Placental Barrier.
    Liu L; Liu X
    Adv Exp Med Biol; 2019; 1141():505-548. PubMed ID: 31571173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ochratoxin A transport by the human breast cancer resistance protein (BCRP), multidrug resistance protein 2 (MRP2), and organic anion-transporting polypeptides 1A2, 1B1 and 2B1.
    Qi X; Wagenaar E; Xu W; Huang K; Schinkel AH
    Toxicol Appl Pharmacol; 2017 Aug; 329():18-25. PubMed ID: 28532671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction.
    Evseenko DA; Murthi P; Paxton JW; Reid G; Emerald BS; Mohankumar KM; Lobie PE; Brennecke SP; Kalionis B; Keelan JA
    FASEB J; 2007 Nov; 21(13):3592-605. PubMed ID: 17595345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.